| Predictors of adverse prognosis in COVID‐19: a systematic review and meta‐analysis S Figliozzi, PG Masci, N Ahmadi, L Tondi, E Koutli, A Aimo, ... European journal of clinical investigation 50 (10), e13362, 2020 | 390 | 2020 |
| Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated? D Oikonomou, G Georgiopoulos, V Katsi, C Kourek, C Tsioufis, ... European journal of gastroenterology & hepatology 30 (9), 979-985, 2018 | 129 | 2018 |
| Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography N Papadopoulos, S Vasileiadi, M Papavdi, E Sveroni, P Antonakaki, ... Annals of gastroenterology 32 (5), 498, 2019 | 63 | 2019 |
| Left ventricular ejection fraction as therapeutic target: is it the ideal marker? V Katsi, G Georgiopoulos, A Laina, E Koutli, J Parissis, C Tsioufis, ... Heart Failure Reviews 22, 641-655, 2017 | 40 | 2017 |
| Azilsartan as a potent antihypertensive drug with possible pleiotropic cardiometabolic effects: a review study G Georgiopoulos, V Katsi, D Oikonomou, G Vamvakou, E Koutli, A Laina, ... Frontiers in Pharmacology 7, 235, 2016 | 34 | 2016 |
| Free androgen index as a determinant of arterial stiffness in menopause: a mediation analysis I Lambrinoudaki, GA Georgiopoulos, F Athanasouli, E Armeni, D Rizos, ... Menopause 24 (6), 635-644, 2017 | 23 | 2017 |
| Cardiovascular disease in juvenile idiopathic arthritis E Arsenaki, P Georgakopoulos, P Mitropoulou, E Koutli, K Thomas, ... Current Vascular Pharmacology 18 (6), 580-591, 2020 | 15 | 2020 |
| Direct-acting antiviral treatment for chronic hepatitis C in people who use drugs in a real-world setting KR Koustenis, O Anagnostou, H Kranidioti, S Vasileiadi, P Antonakaki, ... Annals of Gastroenterology 33 (2), 195, 2020 | 15 | 2020 |
| Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria BR Beumer, JLA van Vugt, G Sapisochin, P Yoon, M Bongini, D Lu, X Xu, ... Journal of Cachexia, Sarcopenia and Muscle 13 (5), 2373-2382, 2022 | 12 | 2022 |
| Comparison of point‐shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non‐alcoholic fatty liver disease D Roccarina, L Iogna Prat, G Pallini, M Guerrero Misas, E Buzzetti, ... Liver International 42 (10), 2195-2203, 2022 | 8 | 2022 |
| The use of APRI and FIB-4 scores versus transient elastography (TE) for the assessment of liver fibrosis stage in patients with chronic hepatitis C (CHC): is it possible to … N Papadopoulos, S Vasileiadi, S Michalea, P Antonakaki, M Papavdi, ... Transfusion 269, 47, 2019 | 5 | 2019 |
| Tu1506–Adherence to follow-up of people who inject drugs (PWID) after the successful treatment of chronic hepatitis C with direct-acting antivirals (DAA) KR Koustenis, E Koutli, H Kranidioti, P Antonakaki, P Pantsas, ... Gastroenterology 156 (6), S-1346, 2019 | 1 | 2019 |
| 441 HEPATITIS C VIRUS (HCV) MICRO-ELIMINATION PROJECT AT OPIOID SUBSTITUTION THERAPY (OST) PROGRAMS IN GREECE O Anagnostou, P Antonakaki, H Kranidioti, M Manolakopoulou, E Koutli, ... Gastroenterology 160 (6), S-779, 2021 | | 2021 |
| Sa323 HCV REINFECTION AFTER SUCCESSFUL TREATMENT WITH DIRECT-ACTING ANTIVIRAL THERAPY (DAA) IN PEOPLE WHO INJECT DRUGS (PWID) M Patsi, KR Koustenis, H Kranidioti, P Fylaktos, S Vasileiadi, ... Gastroenterology 160 (6), S-825, 2021 | | 2021 |
| Non-alcoholic steatohepatitis (NASH)-related cirrhosis is not associated with lower patient eligibility for liver transplantation compared to other liver disease aetiologies E Koutli, A Mantovani, A Marshall, J Ryan, R Westbrook, E Tsochatzis Journal of Hepatology 73, S11-S12, 2020 | | 2020 |
| LOSS OF FOLLOW-UP AFTER DIRECT-ACTING ANTIVIRALS THERAPY AMONG DRUG USERS; AN ADDITIONAL BARRIER TO HCV ELIMINATION K Koustenis, O Anagnostou, C Kranidioti, S Vasileiadi, P Antonakaki, ... HEPATOLOGY 70, 972A-973A, 2019 | | 2019 |
| CHANGES IN SPLEEN STIFFNESS MEASUREMENT IN PATIENTS UNDERGOING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT PLACEMENT AS ASSESSED BY TRANSIENT ELASTOGRAPHY AND SHEAR-WAVE … A Benmassaoud, D Roccarina, E Koutli, DWM Patch, EA Tsochatzis HEPATOLOGY 70, 189A-190A, 2019 | | 2019 |
| Deterioration of vascular and hemodynamic markers during and after pegylated interferon and ribavirin treatment for chronic hepatitis C G Georgiopoulos, A Laina, A Alexopoulou, A Mareti, D Bampatsias, ... EUROPEAN HEART JOURNAL 39, 1119-1119, 2018 | | 2018 |
